Adverse events associated with mood stabiliser treatment should be continuously monitored in patients diagnosed with bipolar affective disorder. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/ebmed-2016-110629
PubMed Identifier: 28254753
Publication URI: http://europepmc.org/abstract/MED/28254753
Type: Journal Article/Review
Volume: 22
Parent Publication: Evidence-based medicine
Issue: 2
ISSN: 1356-5524